title: [Beat therapeutic inertia in dyslipidemic patient management: A challenge in daily clinical practice] [corrected].
abstract: Beat therapeutic inertia in dyslipidemic patient management: a challenge in daily clinical practice. In patients with dyslipidemia, there is the need to reach the therapeutic goals in order to get the maximum benefit in the cardiovascular events risk reduction, especially myocardial infarction. Even having guidelines and some powerful hypolipidemic drugs, the goals of low-density lipoprotein-cholesterol (LDL-c) are often not reached, being of special in patients with a high cardiovascular risk. One of the causes is the therapeutic inertia. There are tools to plan the treatment and make the decisions easier. One of the challenges in everyday clinical practice is to know the needed percentage of reduction in LDL-c. Moreover: it is hard to know which one is the treatment we should use in the beginning of the treatment but also when the desired objective is not reached. This article proposes a practical method that can help solving these questions.
authors.affiliation: Servicio de Medicina Interna, Unidad de Lípidos y Riesgo Vascular, Althaia, Xarxa Assistencial i Universitària de Manresa, Barcelona, España. Electronic address: cmoralescoca@gmail.com.
authors.forename: Clotilde
authors.initials: C
authors.lastname: Morales
authors.affiliation: Servicio de Medicina Interna, Unidad de Lípidos, Hospital de Terrassa, Barcelona, España.
authors.forename: Marta
authors.initials: M
authors.lastname: Mauri
authors.affiliation: Servicio de Endocrinología y Nutrición, Unidad de Lípidos, Hospital Moisès Broggi de Sant Joan Despí, Barcelona, España.
authors.forename: Lluís
authors.initials: L
authors.lastname: Vila
mesh_terms: D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control*; D008078:Cholesterol, LDL / Q000097:blood*; D050171:Dyslipidemias / Q000150:complications / Q000628:therapy*; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D012307:Risk Factors
chemical_list: D008078:Cholesterol, LDL; D000960:Hypolipidemic Agents
keywords: Dislipidemia; Dyslipidemia; Inercia terapéutica; LDL-c; Planificación terapéutica; Therapeutic inertia; Therapy planning; cLDL